abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Historia

3 May 2018

USA: Rise in opioids deaths leads state officials to file claims against drug firms and distributors

The opioid crisis has continued to grow in the United States leading to an increased number of pharmaceutical companies involved in litigation for their responsibility in the dubious marketing and distribution of opioid products. This Story compiles developments about the legal accountability related to pharmaceutical companies' role in creating and exacerbating the opioid epidemic in the United States.

Línea del tiempo